134 related articles for article (PubMed ID: 37105512)
1. Influences of amino-terminal modifications on amyloid fibril formation of human serum amyloid A.
Tanaka M; Takarada T; Nadanaka S; Kojima R; Hosoi K; Machiba Y; Kitagawa H; Yamada T
Arch Biochem Biophys; 2023 Jul; 742():109615. PubMed ID: 37105512
[TBL] [Abstract][Full Text] [Related]
2. Effect of amino acid variations in the central region of human serum amyloid A on the amyloidogenic properties.
Takase H; Tanaka M; Miyagawa S; Yamada T; Mukai T
Biochem Biophys Res Commun; 2014 Jan; 444(1):92-7. PubMed ID: 24440699
[TBL] [Abstract][Full Text] [Related]
3. Acceleration of amyloid fibril formation by carboxyl-terminal truncation of human serum amyloid A.
Tanaka M; Kawakami T; Okino N; Sasaki K; Nakanishi K; Takase H; Yamada T; Mukai T
Arch Biochem Biophys; 2018 Feb; 639():9-15. PubMed ID: 29288051
[TBL] [Abstract][Full Text] [Related]
4. Effect of lipid environment on amyloid fibril formation of human serum amyloid A.
Tanaka M; Nishimura A; Takeshita H; Takase H; Yamada T; Mukai T
Chem Phys Lipids; 2017 Jan; 202():6-12. PubMed ID: 27865770
[TBL] [Abstract][Full Text] [Related]
5. Identification of regions responsible for heparin-induced amyloidogenesis of human serum amyloid A using its fragment peptides.
Egashira M; Takase H; Yamamoto I; Tanaka M; Saito H
Arch Biochem Biophys; 2011 Jul; 511(1-2):101-6. PubMed ID: 21569756
[TBL] [Abstract][Full Text] [Related]
6. Variation of amino acid sequences of serum amyloid a (SAA) and immunohistochemical analysis of amyloid a (AA) in Japanese domestic cats.
Tei M; Uchida K; Chambers JK; Watanabe KI; Tamamoto T; Ohno K; Nakayama H
J Vet Med Sci; 2018 Feb; 80(1):164-172. PubMed ID: 29199213
[TBL] [Abstract][Full Text] [Related]
7. Human lysozyme inhibits the fibrillation of serum amyloid a protein from systemic AA amyloidosis.
Moderer T; Puşcalău-Gîrţu I; Haupt C; Baur J; Rodríguez-Alfonso A; Wiese S; Schmidt CQ; Malešević M; Forssmann WG; Ständker L; Fändrich M
Amyloid; 2023 Dec; 30(4):424-433. PubMed ID: 37431668
[TBL] [Abstract][Full Text] [Related]
8. Structural requirements of glycosaminoglycans for facilitating amyloid fibril formation of human serum amyloid A.
Takase H; Tanaka M; Yamamoto A; Watanabe S; Takahashi S; Nadanaka S; Kitagawa H; Yamada T; Mukai T
Amyloid; 2016 Jun; 23(2):67-75. PubMed ID: 27097047
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of amyloid proteins.
Benson MD; Kluve-Beckerman B; Liepnieks JJ; Murrell JR; Hanes D; Uemichi T
Ciba Found Symp; 1996; 199():104-13; discussion 113-8. PubMed ID: 8915606
[TBL] [Abstract][Full Text] [Related]
10. Aggregation of Mouse Serum Amyloid A Protein Was Promoted by Amyloid-Enhancing Factors with the More Genetically Homologous Serum Amyloid A.
Lin X; Watanabe K; Kuragano M; Tokuraku K
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33494290
[TBL] [Abstract][Full Text] [Related]
11. Recent insights into the pathogenesis of type AA amyloidosis.
van der Hilst JC
ScientificWorldJournal; 2011 Mar; 11():641-50. PubMed ID: 21403980
[TBL] [Abstract][Full Text] [Related]
12. Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.
Patke S; Maheshwari R; Litt J; Srinivasan S; Aguilera JJ; Colón W; Kane RS
Biochemistry; 2012 Apr; 51(14):3092-9. PubMed ID: 22448726
[TBL] [Abstract][Full Text] [Related]
13. The pathogenesis and biochemistry of amyloidosis.
Cohen AS; Connors LH
J Pathol; 1987 Jan; 151(1):1-10. PubMed ID: 3550020
[TBL] [Abstract][Full Text] [Related]
14. Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes.
de Beer MC; de Beer FC; Beach CM; Gonnerman WA; Carreras I; Sipe JD
J Immunol; 1993 Jun; 150(12):5361-70. PubMed ID: 8515064
[TBL] [Abstract][Full Text] [Related]
15. Proteolysis of serum amyloid A and AA amyloid proteins by cysteine proteases: cathepsin B generates AA amyloid proteins and cathepsin L may prevent their formation.
Röcken C; Menard R; Bühling F; Vöckler S; Raynes J; Stix B; Krüger S; Roessner A; Kähne T
Ann Rheum Dis; 2005 Jun; 64(6):808-15. PubMed ID: 15897303
[TBL] [Abstract][Full Text] [Related]
16. In vitro degradation of serum amyloid A by cathepsin D and other acid proteases: possible protection against amyloid fibril formation.
Yamada T; Kluve-Beckerman B; Liepnieks JJ; Benson MD
Scand J Immunol; 1995 Jun; 41(6):570-4. PubMed ID: 7770727
[TBL] [Abstract][Full Text] [Related]
17. Cryo-EM fibril structures from systemic AA amyloidosis reveal the species complementarity of pathological amyloids.
Liberta F; Loerch S; Rennegarbe M; Schierhorn A; Westermark P; Westermark GT; Hazenberg BPC; Grigorieff N; Fändrich M; Schmidt M
Nat Commun; 2019 Mar; 10(1):1104. PubMed ID: 30846696
[TBL] [Abstract][Full Text] [Related]
18. Generation and use of site-specific antibodies to serum amyloid A for probing amyloid A development.
Miura K; Ju ST; Cohen AS; Shirahama T
J Immunol; 1990 Jan; 144(2):610-3. PubMed ID: 2295803
[TBL] [Abstract][Full Text] [Related]
19. N-terminal peptide fragment constitutes core of amyloid deposition of serum amyloid A: An imaging mass spectrometry study.
Shintani-Domoto Y; Sugiura Y; Ogawa M; Sugiyama E; Abe H; Sakatani T; Ohashi R; Ushiku T; Fukayama M
PLoS One; 2022; 17(10):e0275993. PubMed ID: 36240260
[TBL] [Abstract][Full Text] [Related]
20. Animal models for reactive amyloidosis.
Gruys E; Snel FW
Baillieres Clin Rheumatol; 1994 Aug; 8(3):599-611. PubMed ID: 7954864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
